SEC Form 4 · accession 0001209191-17-003452
Aravive, Inc. · ARAV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Westberg
Officer — Sr. VP, Corporate Development
Period of report
Jan 9, 2017
Accepted (ET)
Jan 11, 2017 · 9:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513818
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 9, 2017 | M | 2,312 | $1.265 | A | 46,912 | D | |
| Common Stock | Jan 9, 2017 | M | 11,044 | $1.38 | A | 57,956 | D | |
| Common StockF2 | Jan 9, 2017 | S | 13,356 | $15.93 | D | 44,600 | D | |
| Common Stock | Jan 10, 2017 | M | 10,467 | $1.38 | A | 55,067 | D | |
| Common Stock | Jan 10, 2017 | M | 746 | $1.61 | A | 55,813 | D | |
| Common StockF3 | Jan 10, 2017 | S | 11,213 | $15.66 | D | 44,600 | D | |
| Common Stock | Jan 11, 2017 | M | 7,931 | $1.61 | A | 52,531 | D | |
| Common StockF4 | Jan 11, 2017 | S | 7,931 | $15.24 | D | 44,600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $1.265 | Jan 9, 2017 | M | 2,312 | D | — | Mar 29, 2021 | Common Stock | 2,312 | 0 | D |
| Stock Option (Right to Buy)F5 | $1.38 | Jan 9, 2017 | M | 11,044 | D | — | Apr 30, 2022 | Common Stock | 11,044 | 10,467 | D |
| Stock Option (Right to Buy)F5 | $1.38 | Jan 10, 2017 | M | 10,467 | D | — | Apr 30, 2022 | Common Stock | 10,467 | 0 | D |
| Stock Option (Right to Buy)F6 | $1.61 | Jan 10, 2017 | M | 746 | D | — | Jan 22, 2023 | Common Stock | 746 | 23,524 | D |
| Stock Option (Right to Buy)F6 | $1.61 | Jan 11, 2017 | M | 7,931 | D | — | Jan 22, 2023 | Common Stock | 7,931 | 15,593 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 trading plan.
- F2The shares were sold at prices ranging from $15.75 to $16.35. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The shares were sold at prices ranging from $15.50 to $15.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The shares were sold at prices ranging from $15.00 to $15.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5Fully vested.
- F6Twenty-Five percent of the shares subject to the option become exercisable one year from 1/23/2013; the remainder become exercisable in equal monthly installments over the following three years.